2024-04-10 15:25:24 ET
CRISPR Therapeutics AG (CRSP)
Annual Needham Virtual Healthcare Conference Call
April 10, 2024, 11:45 AM ET
Company Participants
Samarth Kulkarni - Chief Executive Officer and Chairman
Conference Call Participants
Gil Blum - Needham & Company
Presentation
Gil Blum
Good morning, everyone, and thank you for joining us on the Third Day of the Needham Healthcare Conference. My name is Gil Blum and I am a Senior Biotech Analyst with a focus on immune oncology. I have with me today Sam Kulkarni, CEO of CRISPR Therapeutics. And as a reminder, any viewers who are watching through our conference portal are able to submit questions via the ask a question box below the video feed window.
And with that, Sam, I think we can, you know, have a bit of an introduction, although I feel most people should be familiar with CRISPR.
Question-and-Answer Session
Q - Gil Blum
So from a 50,000 foot view and given, you know, recent historic approval for CASGEVY. How should investors view the upcoming year 2024 regarding CRISPR strategy and drivers?...
Read the full article on Seeking Alpha
For further details see:
CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference - (Transcript)